Page 134 - Ciences News Today

- atai has initiated a Phase 1 proof-of-concept clinical trial to demonstrate the safety, tolerability, and direct-to-brain delivery of intranasal INB-01, a sol-gel based drug-delivery technology. -

- New Clinical and Patient-Reported Outcomes in People with HIV on Biktarvy in Observational BICSTaR Study Demonstrate Consistent Efficacy Profile in Real-World Setting - - Long-Term Switch Data

NOTTINGHAM, England, Oct. 18, 2022 /PRNewswire/ -- Quotient Sciences, the drug development and manufacturing accelerator, has completed the expansion of its drug substance manufacturing facility

DUBAI, UAE, Oct. 18, 2022 /PRNewswire/ -- According to an official announcement made recently in Dubai, Prof. Ian Hector Frazer and the Late Dr. Jian Zhou are the winners of the Grand Hamdan

Pêche : accroître la production locale de poissons

BASEL, Switzerland, Oct. 14, 2022 -- In a release issued under the headline Myovant Sciences to Host Second Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m. earlier today by Myovant... | October 14, 2022

- Five posters will highlight clinical data for VTAMA cream for the treatment of plaque psoriasis in adults and for atopic dermatitis in patients as young as two - Dermavant Sciences, a biopharmaceutical

St. Pölten UAS Project among Best Inventions and Discoveries in "100 Years of Lower Austria" The province of Lower Austria presented the best inventions and discoveries by Lower Austrian

Professor Doreen Cantrell, Wellcome Trust Principal Research Fellow at the University of Dundee’s School of Life Sciences, has been appointed as one of two new trustees of Cancer Research UK one of the world’s biggest cancer charities. Click to read more...

Fund will support University to develop farm solutions to increase efficiency in crop production The AGCO Agriculture Foundation (AAF), a private foundation with the vision to prevent and relieve